Core Laboratories Inc
CLB: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$44.00 | Stq | Dtxqstmpd |
Solid Fourth Quarter for Core Laboratories Driven by Steadily Climbing Production Activity Worldwide
Wide-moat Core Laboratories concluded the year on sound footing. Results for fiscal 2022 fell in line with our expectations, with total revenue increasing 4% year over year and operating margins slightly contracting to 8% from 10% in 2021. We’ll incorporate the firm’s full financial and operating results shortly, but based on our initial review, our $29 per share fair value estimate is unchanged.